Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Moodys
Federal Trade Commission
Cerilliant
Colorcon
Medtronic
Merck
Baxter
Daiichi Sankyo

Generated: May 25, 2018

DrugPatentWatch Database Preview

Bentiromide - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for bentiromide and what is the scope of bentiromide patent protection?

Bentiromide
is the generic ingredient in one branded drug marketed by Savage Labs and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for bentiromide.
Summary for bentiromide
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 3
Bulk Api Vendors: 12
Patent Applications: 177
DailyMed Link:bentiromide at DailyMed
Synonyms for bentiromide
(S)-4-((2-(benzoylamino)-3-(4-hydroxyphenyl) -1-oxopropyl)amino)benzoic acid
(S)-4-((2-(Benzoylamino)-3-(4-hydroxyphenyl)-1-oxopropyl)amino)benzoic acid
(S)-p-(|A-benzamido-p-hydroxyhydrocinnamamido) benzoic acid
(S)-p-(alpha-Benzamido-p-hydroxyhydrocinnamamido)benzoic acid
106B971
2260AH
239IF5W61J
37106-97-1
4-(N-benzoyl-L-tyrosylamino)benzoic acid
4-[(2S)-3-(4-hydroxyphenyl)-2-(phenylformamido)propanamido]benzoic acid
4-[(N-benzoyl-L-tyrosyl)amino]benzoic acid
AB01566933_01
ACM37106971
Bentiromide [USAN:INN:BAN:JAN]
Bentiromido
Bentiromido [INN-Spanish]
Bentiromidum
Bentiromidum [INN-Latin]
Benzoyltyrosyl-p-aminobenzoic acid
Benzoyltyrosyl-p-aminobenzoic acid (Btpaba)
BRN 2910938
BT-PABA
Btpaba
Btpaba Pft
BTPABA, PFT
BZ-TYR-4-ABZ-OH
C12779
CHEBI:31263
CHEMBANK2959
CHEMBL1200368
Chymex
D01346
D0L0SW
DB00522
DTXSID2048377
E 2663
E-2663
EINECS 253-349-8
K-8226
MFCD00055768
N-benzoyl-L-tyrosyl-p-aminobenzoate
N-Benzoyl-L-tyrosyl-p-aminobenzoic acid
p-((N-Benzoyl-L-tyrosin)amido)benzoic acid
PFT
Ro 11-7891
SCHEMBL151634
SR-01000883958
SR-01000883958-1
UNII-239IF5W61J
ZINC608204

US Patents and Regulatory Information for bentiromide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Savage Labs CHYMEX bentiromide SOLUTION;ORAL 018366-001 Dec 29, 1983 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for bentiromide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Savage Labs CHYMEX bentiromide SOLUTION;ORAL 018366-001 Dec 29, 1983 ➤ Try a Free Trial ➤ Try a Free Trial
Savage Labs CHYMEX bentiromide SOLUTION;ORAL 018366-001 Dec 29, 1983 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Deloitte
McKinsey
Accenture
Chinese Patent Office
US Department of Justice
Boehringer Ingelheim
Teva
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.